Congenital hepatoblastoma and schizencephaly in an infant with Beckwith- Wiedemann syndrome

Medical and Pediatric Oncology

Volumn 33, Issue 6, 1999, Pages 591-593

  Worth, Laura L ^a   Slopis, John M ^b   Herzog, Cynthia E ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Beckwith Wiedemann syndrome; Hepatoblastoma; Schizencephaly; Seizures

Indexed keywords

ARTICLE; BECKWITH WIEDEMANN SYNDROME; CASE REPORT; CHILD; HEPATOBLASTOMA; HUMAN; KIDNEY METABOLISM; LIVER METABOLISM; LIVER TUMOR; MALE; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHIZENCEPHALY; STOMACH OBSTRUCTION;

BECKWITH-WIEDEMANN SYNDROME; BRAIN; HEPATOBLASTOMA; HUMANS; INFANT, NEWBORN; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; SEIZURES;

EID: 0032711844     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199912)33:6<591::AID-MPO15>3.0.CO;2-T     Document Type: Article

References (17)

1. Endo EG, Walton DS, Albert DM. Neonatal hepatoblastoma metastatic to the choriod and iris. Arch Ophthamol 1996;114:757-761.
2. Herrera Savall M, Perez Payarols J, Henales Villate V, et al. Hepatoblastoma. Presentacion de un caso diagnosticado intrautero. An Esp Pediatr 1993;39:265-267.
3. von Schweinitz D, Byrd DJ, Hecker H, et al. Efficiency and toxicity of ifosfamide, cisplatin, and doxorubicin in the treatment of childhood hepatoblastoma. Eur J Cancer 1997;33:1243-1249.
4. Saxena R, Leaks JL, Shafford EA, et al. Chemotherapy effects on hepatoblastoma. Am J Surg Pathol 1993;17:1266-1271.
5. Ninane J, Perilongo G, Stalens J-P, et al. Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: a SIOP pilot study. Med Pediatr Oncol 1991;19:199-203.
6. Exelby PR, Filler RM, Grosfeld JL. Liver tumors in children in the particular reference to hebatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey - 1974. J Pediatr Surg 1975;10:329-337.
7. Ortega JA, Krailo MD, Haas JE. et al. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group. J Clin Oncol 1991;9:2167-2176.
8. Douglass EC, Reynolds M, Finegold M, et al. Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study. J Clin Oncol 1993;11:96-99.
9. Wiedemann H-R: Tumours and hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur J Padiatr 1983;141:129.
10. Gurney JG, Severson RK, Davis S, et al. Incidence of cancer in children in the United States. Cancer 1995;75:2186-2195.
11. Kenney LB, Miller BA, Gloeker-Reis LA, et al. Increasing incidence of cancer in US infants, 1980-1990. Pediatr Res 1995;37: 159A.
12. Neims AH, Warner M, Loughman PM, et al. Developmental aspects of the hepatic cytochrome P450 monooxygenase system. Annu Rev Pharmacol Toxicol 1976;16:427-445.
13. Holiday MA, Barratt TM, Vernier RL, editors. Pediatric nephrology. Baltimore: Williams & Wilkins; 1987.
14. Wagstaff AJ, Ward A, Benfield P, et al. Carboplatin: a preliminary review of its pharmacodynamics and pharmacokinetic properties and therapeutic efficiency in the treatment of cancer. Drugs 1989; 37:162-190.
15. Martinez-Martinez R, Martinez-Carboney R, Ocampo-Campos R, et al. Wiedemann-Beckwith syndrome: clinical, cytogenetical and radiological observations in 39 new cases. Genet Counsel 1992; 3:67-76.
16. Volpe JJ, editor. Neurology of the newborn, 2nd ed. Philadelphia: W.B. Saunders; 1987.
17. Hoovers JM, Kalikin LM, Johnson L, et al. Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments. Proc Natl Acad Sci USA 1995;92:12456-12460.